Melissa Fisher, AFTD Ambassador and a senior strategic marketing consultant at Kaiser Permanente Northwest, shared the realities of being an FTD care partner while emphasizing emphasized the need for better dementia care pathways in an episode of VIE Healthcare’s podcast. Caregiving is difficult; most family care partners are unpaid, untrained, and often overwhelmed. Yet, care…

Amisulpride, an antipsychotic drug, is capable of reducing aggregation of the tau protein in cell and mouse models, according to a study published earlier this year. While the drug could be a potential disease-modifying treatment for tau-based FTD, further trials with human participants are necessary. Tau is one of a few proteins that can accumulate…